Children's Hospital is part of the UPMC family.
This is a multicenter observational study to gather information about specific aspects of growth hormone replacement therapy using recombinant DNA growth hormone from Genentech. The primary objective of this long-term study is to collect safety and efficacy information regarding use of these therapies in treatment of children who have growth failure due to lack of adequate endogenous growth hormone secretion, short stature due to chronic renal insufficiency and Turner Syndrome.
Children of either sex up to age 17 who are being treated with Genentech’s Nutropin®, Nutropin AQ or Protropin® for growth failure are eligible to participate, subject to certain exclusions.
Boys: All ages
Girls: All ages
Participation will only involve data collection, starting during each participant’s first treatment with growth hormone, and will continue during subsequent routine visits with the child’s doctor. The study will collect and record all medical record information from lab tests, x-rays and clinic visits.
Visits: None beyond normal clinical care
Duration: Until patient is no longer seen in clinic
Study Description at National Institutes of Health
Oscar Escobar, MD
To get started, pleasse contact:
Ana Diaz, RN
Virginia Stefanick, RN
Children's Hospital's main campus is located in the Lawrenceville neighborhood. Our main hospital address is:
Children’s Hospital of Pittsburgh of UPMC
One Children’s Hospital Way
4401 Penn Ave.
Pittsburgh, PA 15224
In addition to the main hospital, Children's has many convenient locations in other neighborhoods throughout the greater Pittsburgh region.
With myCHP, you can request appointments, review test results, and more.
For questions about a hospital bill call:
To pay your bill online, please visit UPMC's online bill payment system.
Interested in giving to Children's Hospital? Visit Children's Hospital of Pittsburgh Foundation's website to: